MedTrace Logo

ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?

NCT02602574 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2022-05-18

No results posted yet for this study

Summary

Post endoscopic pancreatitis (PEP) has different initial immunologic response to primary injury compared to acute pancreatitis of other etiology (non-PEP AP).

The purpose of this study is to compare initial immunologic response, 24 h after primary injury, in patients with PEP and patients with acute pancreatitis of other etiology.

Conditions

  • Post-ERCP Acute Pancreatitis

Interventions

OTHER

heparinized peripheral venous blood and urine sample.

All patients will be taken heparinized peripheral venous blood and urine sample

Sponsors & Collaborators

  • University Hospital Rijeka

    lead OTHER

Principal Investigators

  • Davor Štimac, MD, PhD · Clinical Hospital Centre Rijeka

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2023-08-31
Completion
2024-01-31

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602574 on ClinicalTrials.gov